Denovo Biopharma

Denovo Biopharma is a privately held biotechnology company providing novel biomarker solutions for personalized medicine development. The core technology is the industry's first platform and algorithm for de novo genomic biomarker discovery using archived clinical samples retrospectively. This technology is particularly useful for late-stage clinical drugs with trials that have already been completed but showed unsatisfactory results. By retrospectively identifying biomarkers associated with patients' responses to candidate drugs, our technology enables biotech and pharmaceutical companies to design new clinical trials in targeted patient populations to achieve significant efficacy and/or fewer side effects. Our platform can be widely applied to biomarker discovery across many therapeutic areas, such as oncology, metabolism, cardiology, immunology, and neurology.